News & Media

When EVs meet Alzheimer’s disease – exploring this fascinating area of research in light of World Alzheimer’s Month 2021.

Notes from a conversation with Assistant Professor Stephanie Jung, University Hospital of Bonn (Germany), who separated Hepatitis B and antibodies from EVs to enable functional EV-virology studies.

Sharing the story of France-based researcher Dr Gwennan André-Grégoire, who is working on unravelling the EV-related pathophysiology of glioblastoma multiforme.

Four reasons why storage conditions matter to the world of extracellular vesicle research.

An optimised, clinically relevant method for proteomic analysis of plasma EVs, featuring qEV isolation, is now documented in Cell Reports Methods.

On World Hepatitis Day 2021, we explore how researchers are pursuing extracellular vesicles as a way to improve outcomes for people with hepatitis.

Highlights from the third ISEV 2021 plenary talk by Simon Carding, University of East Anglia, who discussed bacteria-derived EVs, their dynamics in the gut and their potential as drug delivery vehicles.

A wrap-up of the second ISEV 2021 plenary talk by Chantal Boulanger, INSERM. Here, the focus was on EVs in relation to arterial contraction and myocardial infarction.

A summary of the first ISEV 2021 plenary session by Andrew Hill, La Trobe University. This presentation explored EVs and their role in neurogenerative diseases, with a particular focus on prion diseases.

Together, the qEV Concentration Kit and qEV RNA Extraction Kit provide streamlined and standardised solutions for isolating and concentrating EVs and extracting EV-RNA for downstream analysis.

To help you select a suitable method for your research, we identified three key questions that get to the core of what’s important for characterising nanoparticles.

How is TRPS used to derive EV characteristics? How has a post-processing protocol created new possibilities for zeta potential analysis? Find out in this wrap-up of the ISEV2021 presentation by Dr. Priscila Dauros-Singorenko.

In brief: a summary of work by Vogel et al. (2021), who compared six methods for nanoparticle analysis, and assessed their capabilities using synthetic and biological nanovesicles of varying complexity.

To strengthen the analysis of nanoparticle size, concentration, and charge, Izon Science has released the Exoid – a new-generation Tunable Resistive Pulse Sensing (TRPS) technology.

If you are yet to join the high-definition revolution, we recommend you read these three studies that harness the accuracy of TRPS measurements.

Two researchers from the Paris Cardiovascular Research Centre, Dr. Pierre-Michaël Coly and Stephane Mazlan, discuss how they are decoding the role of EVs in cardiovascular health.